Your browser doesn't support javascript.
loading
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients.
Cassotta, Antonino; Mikol, Vincent; Bertrand, Thomas; Pouzieux, Stéphanie; Le Parc, Josiane; Ferrari, Paul; Dumas, Jacques; Auer, Michael; Deisenhammer, Florian; Gastaldi, Matteo; Franciotta, Diego; Silacci-Fregni, Chiara; Fernandez Rodriguez, Blanca; Giacchetto-Sasselli, Isabella; Foglierini, Mathilde; Jarrossay, David; Geiger, Roger; Sallusto, Federica; Lanzavecchia, Antonio; Piccoli, Luca.
Affiliation
  • Cassotta A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Mikol V; Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
  • Bertrand T; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Pouzieux S; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Le Parc J; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Ferrari P; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Dumas J; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Auer M; Research Platform, Sanofi R&D, Vitry-sur-Seine, France.
  • Deisenhammer F; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Gastaldi M; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Franciotta D; Laboratory of Neuroimmunology, IRCCS Mondino Foundation, Pavia, Italy.
  • Silacci-Fregni C; Laboratory of Neuroimmunology, IRCCS Mondino Foundation, Pavia, Italy.
  • Fernandez Rodriguez B; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Giacchetto-Sasselli I; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Foglierini M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Jarrossay D; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Geiger R; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Lanzavecchia A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Piccoli L; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Nat Med ; 25(9): 1402-1407, 2019 09.
Article in En | MEDLINE | ID: mdl-31501610
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epitopes, T-Lymphocyte / Antibodies, Neutralizing / Natalizumab / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epitopes, T-Lymphocyte / Antibodies, Neutralizing / Natalizumab / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2019 Document type: Article Affiliation country: Country of publication: